A directed approach for engineering conditional protein stability using biologically silent small molecules

被引:51
作者
Maynard-Smith, Lystranne A.
Chen, Ling-Chun
Banaszynski, Laura A.
Ooi, A. G. Lisa
Wandless, Thomas J.
机构
[1] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Chem, Stanford, CA 94305 USA
关键词
D O I
10.1074/jbc.M703902200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ability to regulate the function of specific proteins using cell-permeable molecules can be a powerful method for interrogating biological systems. To bring this type of "chemical genetic" control to a wide range of proteins, we recently developed an experimental system in which the stability of a small protein domain expressed in mammalian cells depends on the presence of a high affinity ligand. This ligand-dependent stability is conferred to any fused partner protein. The FK506-and rapamycin-binding protein (FKBP12) has been the subject of extensive biophysical analyses, including both kinetic and thermodynamic studies of the wild-type protein as well as dozens of mutants. The goal of this study was to determine if the thermodynamic stabilities (Delta Delta G(U-F)) of various amino acid substitutions within a given protein are predictive for engineering additional ligand-dependent destabilizing domains. We used FKBP12 as a model system and found that in vitro thermodynamic stability correlates weakly with intracellular degradation rates of the mutants and that the ability of a given mutation to destabilize the protein is context-dependent. We evaluated several new FKBP12 ligands for their ability to stabilize these mutants and found that a cell-permeable molecule called Shield-1 is the most effective stabilizing ligand. We then performed an unbiased microarray analysis of NIH3T3 cells treated with various concentrations of Shield-1. These studies show that Shield-1 does not elicit appreciable cellular responses.
引用
收藏
页码:24866 / 24872
页数:7
相关论文
共 25 条
[1]   A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules [J].
Banaszynski, Laura A. ;
Chen, Lin-chun ;
Maynard-Smith, Lystranne A. ;
Ooi, A. G. Lisa ;
Wandless, Thomas J. .
CELL, 2006, 126 (05) :995-1004
[2]   Quantitative analyses of bifunctional molecules [J].
Braun, PD ;
Wandless, TJ .
BIOCHEMISTRY, 2004, 43 (18) :5406-5413
[3]   A MAMMALIAN PROTEIN TARGETED BY G1-ARRESTING RAPAMYCIN-RECEPTOR COMPLEX [J].
BROWN, EJ ;
ALBERS, MW ;
SHIN, TB ;
ICHIKAWA, K ;
KEITH, CT ;
LANE, WS ;
SCHREIBER, SL .
NATURE, 1994, 369 (6483) :756-758
[4]   Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme [J].
Canet, D ;
Last, AM ;
Tito, P ;
Sunde, M ;
Spencer, A ;
Archer, DB ;
Redfield, C ;
Robinson, CV ;
Dobson, CM .
NATURE STRUCTURAL BIOLOGY, 2002, 9 (04) :308-315
[5]   Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity [J].
Clackson, T ;
Yang, W ;
Rozamus, LW ;
Hatada, M ;
Amara, JF ;
Rollins, CT ;
Stevenson, LF ;
Magari, SR ;
Wood, SA ;
Courage, NL ;
Lu, XD ;
Cerasoli, F ;
Gilman, M ;
Holt, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (18) :10437-10442
[6]   INHIBITION OF PROTEASOME ACTIVITIES AND SUBUNIT-SPECIFIC AMINO-TERMINAL THREONINE MODIFICATION BY LACTACYSTIN [J].
FENTEANY, G ;
STANDAERT, RF ;
LANE, WS ;
CHOI, S ;
COREY, EJ ;
SCHREIBER, SL .
SCIENCE, 1995, 268 (5211) :726-731
[7]   Mapping the interactions present in the transition state for unfolding/folding of FKBP12 [J].
Fulton, KF ;
Main, ERG ;
Daggett, V ;
Jackson, SE .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 291 (02) :445-461
[8]   An efficient proteomics method to identify the cellular targets of protein kinase inhibitors [J].
Godl, K ;
Wissing, J ;
Kurtenbach, A ;
Habenberger, P ;
Blencke, S ;
Gutbrod, H ;
Salassidis, K ;
Stein-Gerlach, M ;
Missio, A ;
Cotten, M ;
Daub, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (26) :15434-15439
[9]   Intravenous safety and pharmacokinetics of a novel dimerizer drug, AP1903, in healthy volunteers [J].
Iuliucci, JD ;
Oliver, SD ;
Morley, S ;
Ward, C ;
Ward, J ;
Dalgarno, D ;
Clackson, T ;
Berger, HJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (08) :870-879
[10]   Linkage between ATP consumption and mechanical unfolding during the protein processing reactions of an AAA+ degradation machine [J].
Kenniston, JA ;
Baker, TA ;
Fernandez, JM ;
Sauer, RT .
CELL, 2003, 114 (04) :511-520